Transplant glomerulopathy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Transplant glomerulopathy
Transplant glomerulopathy under very high magnification
Synonyms
Pronounce	N/A
Specialty	N/A
Symptoms	Proteinuria, hypertension, edema, renal dysfunction
Complications	Chronic kidney disease, graft failure
Onset	Months to years post-kidney transplant
Duration	Chronic
Types	N/A
Causes	Chronic antibody-mediated rejection, endothelial injury
Risks	HLA mismatch, non-adherence to immunosuppressive therapy
Diagnosis	Renal biopsy, serology
Differential diagnosis	Chronic rejection, recurrent glomerulonephritis
Prevention	Adequate immunosuppression, HLA matching
Treatment	Immunosuppressive therapy, plasmapheresis, IVIG
Medication	N/A
Prognosis	Variable, often poor if untreated
Frequency	Occurs in 5-20% of kidney transplant recipients
Deaths	N/A

Transplant Glomerulopathy

Micrograph of transplant glomerulopathy, showing characteristic changes.

Transplant glomerulopathy is a chronic kidney disease that occurs in the setting of kidney transplantation. It is characterized by specific changes in the glomeruli, the filtering units of the kidney, and is a significant cause of chronic allograft dysfunction.

Pathophysiology

Transplant glomerulopathy is primarily associated with chronic antibody-mediated rejection (AMR). The condition is marked by the presence of double contours of the glomerular basement membrane, which are visible under a microscope. These changes are thought to result from endothelial injury caused by donor-specific antibodies (DSAs) targeting the transplanted kidney.

Clinical Presentation

Patients with transplant glomerulopathy often present with proteinuria, hypertension, and a gradual decline in renal function. The condition is usually detected during routine follow-up of kidney transplant recipients, often through a kidney biopsy.

Diagnosis

The diagnosis of transplant glomerulopathy is confirmed by histopathological examination of a kidney biopsy. The key histological feature is the presence of double contours of the glomerular basement membrane, which can be identified using special stains such as silver stain or periodic acid-Schiff stain.

Treatment

Management of transplant glomerulopathy involves addressing the underlying cause, which is often chronic antibody-mediated rejection. Treatment strategies may include the use of immunosuppressive therapy to reduce the activity of DSAs. In some cases, plasmapheresis or intravenous immunoglobulin (IVIG) may be used to lower antibody levels.

Prognosis

The prognosis of transplant glomerulopathy varies depending on the severity of the condition and the response to treatment. It is a progressive disease that can lead to graft loss if not adequately managed. Early detection and intervention are crucial to improving outcomes.

See also

• Kidney transplantation
• Chronic allograft nephropathy
• Antibody-mediated rejection